NO962841D0 - Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler - Google Patents

Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler

Info

Publication number
NO962841D0
NO962841D0 NO962841A NO962841A NO962841D0 NO 962841 D0 NO962841 D0 NO 962841D0 NO 962841 A NO962841 A NO 962841A NO 962841 A NO962841 A NO 962841A NO 962841 D0 NO962841 D0 NO 962841D0
Authority
NO
Norway
Prior art keywords
colon cancer
hydroxy
chemopreventives
phenylazobenzoic acid
acid derivatives
Prior art date
Application number
NO962841A
Other languages
English (en)
Other versions
NO962841L (no
Inventor
Lorin K Johnson
Marvin H Sleisenger
Original Assignee
Salix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salix Pharmaceuticals Inc filed Critical Salix Pharmaceuticals Inc
Publication of NO962841D0 publication Critical patent/NO962841D0/no
Publication of NO962841L publication Critical patent/NO962841L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO962841A 1994-01-07 1996-07-05 Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler NO962841L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/178,578 US5498608A (en) 1994-01-07 1994-01-07 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
PCT/US1995/000055 WO1995018622A1 (en) 1994-01-07 1995-01-06 Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents

Publications (2)

Publication Number Publication Date
NO962841D0 true NO962841D0 (no) 1996-07-05
NO962841L NO962841L (no) 1996-08-29

Family

ID=22653104

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962841A NO962841L (no) 1994-01-07 1996-07-05 Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler

Country Status (18)

Country Link
US (1) US5498608A (no)
EP (1) EP0738152B1 (no)
JP (4) JPH09510958A (no)
CN (1) CN1140994A (no)
AT (1) ATE308327T1 (no)
AU (1) AU691869B2 (no)
CA (1) CA2180571C (no)
CZ (1) CZ286460B6 (no)
DE (1) DE69534564T2 (no)
DK (1) DK0738152T3 (no)
ES (1) ES2248796T3 (no)
FI (1) FI962735A (no)
HU (1) HUT74512A (no)
NO (1) NO962841L (no)
NZ (1) NZ279062A (no)
RO (1) RO116525B1 (no)
RU (1) RU2161487C2 (no)
WO (1) WO1995018622A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
US6166024A (en) * 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
US6231888B1 (en) 1996-01-18 2001-05-15 Perio Products Ltd. Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
SE9700934D0 (sv) * 1997-03-14 1997-03-14 Astra Ab New formulation
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
WO2000007577A2 (de) 1998-08-06 2000-02-17 Wolfgang Stremmel Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
AU2001267823A1 (en) * 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Compounds exhibiting x-type spla2 inhibiting effect
WO2002018324A2 (en) 2000-08-29 2002-03-07 Nobex Corporation Immunoregulatory compounds, derivatives thereof and their use
TWI314457B (no) * 2001-03-19 2009-09-11 Shionogi & Co
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
US7825132B2 (en) 2002-08-23 2010-11-02 Novartis Vaccines And Diagnostics, Inc. Inhibition of FGFR3 and treatment of multiple myeloma
KR20050075005A (ko) 2002-11-13 2005-07-19 카이론 코포레이션 암을 치료하는 방법 및 관련 방법
AU2005209948B2 (en) 2004-02-06 2009-09-10 Pharmatel (R&D) Pty Limited Use of aminosalicylates in diarrhoea-predominent Irritable Bowel Syndrome
RU2377988C2 (ru) 2004-02-20 2010-01-10 Новартис Вэксинес Энд Дайэгностикс, Инк. Модуляция воспалительных и метастатических процессов
FR2867981B1 (fr) 2004-03-24 2008-10-31 Genevrier Sa Lab Utilisation des chondroitine mono-et disulfates en therapeutique
JP5009152B2 (ja) * 2004-05-28 2012-08-22 サリックス ファーマシューティカルズ， インコーポレイテッド 放射線誘発性腸炎の予防、処置、および回復
CA2556373C (en) * 2004-05-28 2012-09-04 Salix Pharmaceuticals, Inc. Prevention, treatment, and amelioration of radiation induced enteritis
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
WO2006124413A2 (en) 2005-05-13 2006-11-23 Novartis Ag Methods for treating drug resistant cancer
CN103948609A (zh) 2005-08-24 2014-07-30 萨利克斯药品公司 巴柳氮制剂及其生产和应用
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
RU2354384C1 (ru) * 2007-12-28 2009-05-10 Михаил Владимирович Кутушов Применение органических красителей в качестве средства для лечения онкологических заболеваний
US8569466B2 (en) * 2008-09-10 2013-10-29 Nnochiri Ekwuribe Aromatic carboxylic acid derivatives for treatment and prophylaxis of gastrointestinal diseases including colon cancers
EP2298321A1 (en) 2009-08-26 2011-03-23 Nordic Pharma Novel pharmaceutical compositions for treating IBD
CA2797560A1 (en) 2010-04-26 2011-11-03 Salix Pharmaceuticals, Ltd. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2080796B (en) * 1980-07-21 1983-10-12 Biorex Laboratories Ltd 2-hydroxy-5-phenylazobenzoic acid derivatives
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
US5162202A (en) * 1989-12-12 1992-11-10 Shamsuddin Abulkalam M Rectal mucus test and kit for detecting cancerous and precancerous conditions
US5498608A (en) * 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents

Also Published As

Publication number Publication date
NZ279062A (en) 1999-11-29
WO1995018622A1 (en) 1995-07-13
RO116525B1 (ro) 2001-03-30
CA2180571A1 (en) 1995-07-13
EP0738152A4 (en) 2000-12-13
CZ196796A3 (en) 1996-12-11
HU9601846D0 (en) 1996-09-30
AU1557595A (en) 1995-08-01
ES2248796T3 (es) 2006-03-16
FI962735A0 (fi) 1996-07-03
NO962841L (no) 1996-08-29
HUT74512A (en) 1997-01-28
DK0738152T3 (da) 2006-01-30
ATE308327T1 (de) 2005-11-15
DE69534564T2 (de) 2006-07-27
CZ286460B6 (en) 2000-04-12
JP2005320326A (ja) 2005-11-17
DE69534564D1 (de) 2005-12-08
AU691869B2 (en) 1998-05-28
US5498608A (en) 1996-03-12
RU2161487C2 (ru) 2001-01-10
JP2006096738A (ja) 2006-04-13
EP0738152B1 (en) 2005-11-02
CN1140994A (zh) 1997-01-22
JPH09510958A (ja) 1997-11-04
EP0738152A1 (en) 1996-10-23
FI962735A (fi) 1996-08-26
JP2010235629A (ja) 2010-10-21
CA2180571C (en) 2001-03-20
JP4601466B2 (ja) 2010-12-22

Similar Documents

Publication Publication Date Title
NO962841D0 (no) Anvendelse av 2-hydroksy-5-fenylazobenzosyrederivater som colon cancer kjemopreventativer og kjemoterapeutiske midler
DK1033981T3 (da) Formuleringer og fremgangsmåder til nedsættelse af antineoplastiske midlers toksicitet
ATE424810T1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
ATE277929T1 (de) Immunsuppressive wirkungen von pteridinderivaten
IS2148B (is) (Metýlsúlfónýl)fenýl-2-(5H)-fúranón sem COX-2 hindrar
ATE306261T1 (de) Antithrombosemittel
ES2195344T3 (es) Composicion farmaceutica que presenta una actividad antitumoral mejorada y/o efectos secundarios reducidos, que contiene un agente antitumoral y un derivado de acido hidroximico.
NO985711D0 (no) Farmas°ytikum for behandling av neurologiske og neuropsykiatriske mangler
DE69830504D1 (de) Antithrombotische mitteln
DE69710065T2 (de) Androsten-derivate
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
TR199900336T2 (xx) EAA antagonistleri olarak tetrahidrokinolin t�revleri.
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
DE69930648D1 (de) Orale darreichungsform für pyridin-2-ylmethylsulfinyl-1h-benzimidazole
DE69819539D1 (de) Antithrombotische mittel
DE69931378D1 (de) Chinazolin derivate und therapeutische verwendungen davon
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
SE9403137D0 (sv) Derivatives of carbohydrates and compositions containing them
TNSN99158A1 (ar) طريقة لمنع الاصابة بالربو
HUP9903369A2 (hu) 8(9)-Dehidroösztradiol-származékok
ATE268768T1 (de) Antithrombosemittel